Kos Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Bikaner, Rajasthan, India, established in 2024.
2024 Bikaner, Rajasthan, India Active
Last Updated:
Access Report
About Kos Pharmaceuticals Private Limited

Kos Pharmaceuticals Private Limited, a active private limited company, was established on 04 September 2024 in Bikaner, Rajasthan, India. it holds CIN: U47720RJ2024PTC097056. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Arati Purohit (Director), Neetu Upadhyay (Director). Its latest AGM occurred on 04 December 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Kalawati, Purohit Big, Bigga Bas, Bikaner, Rajasthan, 331803.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47720RJ2024PTC097056

  • Registration Number

    097056

  • Incorporation Date

    04 September 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Kos Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kos Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Arati Purohit Director 04 Sep 2024 Current
Neetu Upadhyay Director 04 Sep 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kos Pharmaceuticals.

Enhance accessibility to Kos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kos Pharmaceuticals revenue growth over time
Kos Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kos Pharmaceuticals?

Unlock access to Kos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kos Pharmaceuticals?

Unlock and access historical data on people associated with Kos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kos Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kos Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Kos Pharmaceuticals Private Limited last Annual general meeting of members was held on 04 Dec 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Kos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was recorded as a recent event.

  • Director Appointment

    The activity Arati Purohit was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Director Appointment

    The activity Neetu Upadhyay was appointed as a Director was appointed as a Director on 04 Sep 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Company Incorporation

    Kos Pharmaceuticals Private Limited was registered on 04 Sep 2024 with Roc Jaipur & aged 1 year 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kos Pharmaceuticals Private Limited?

The CIN of Kos Pharmaceuticals Private Limited is U47720RJ2024PTC097056.

Where is Kos Pharmaceuticals Private Limited headquartered?

Kos Pharmaceuticals Private Limited is headquartered at C/O Kalawati, Purohit Big, Bigga Bas, Bikaner, Rajasthan, 331803.

When was Kos Pharmaceuticals Private Limited incorporated?

Kos Pharmaceuticals Private Limited was incorporated on 04 September 2024.

Who are the current directors of Kos Pharmaceuticals Private Limited?

The current directors of Kos Pharmaceuticals Private Limited are

Is Kos Pharmaceuticals Private Limited a listed company?

Kos Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kos Pharmaceuticals Private Limited?

The authorized capital of Kos Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available